Cargando…

P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION

Detalles Bibliográficos
Autores principales: Danylesko, Ivetta, Shem-Tov, Noga, Yerushalmi, Ronit, Jacoby, Elad, Toren, Amos, Itzhaki, Orit, Shouval, Roni, Shimoni, Avichai, Abraham, Avigdor, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428820/
http://dx.doi.org/10.1097/01.HS9.0000968988.43699.64
_version_ 1785090561920729088
author Danylesko, Ivetta
Shem-Tov, Noga
Yerushalmi, Ronit
Jacoby, Elad
Toren, Amos
Itzhaki, Orit
Shouval, Roni
Shimoni, Avichai
Abraham, Avigdor
Nagler, Arnon
author_facet Danylesko, Ivetta
Shem-Tov, Noga
Yerushalmi, Ronit
Jacoby, Elad
Toren, Amos
Itzhaki, Orit
Shouval, Roni
Shimoni, Avichai
Abraham, Avigdor
Nagler, Arnon
author_sort Danylesko, Ivetta
collection PubMed
description
format Online
Article
Text
id pubmed-10428820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288202023-08-17 P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION Danylesko, Ivetta Shem-Tov, Noga Yerushalmi, Ronit Jacoby, Elad Toren, Amos Itzhaki, Orit Shouval, Roni Shimoni, Avichai Abraham, Avigdor Nagler, Arnon Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428820/ http://dx.doi.org/10.1097/01.HS9.0000968988.43699.64 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Danylesko, Ivetta
Shem-Tov, Noga
Yerushalmi, Ronit
Jacoby, Elad
Toren, Amos
Itzhaki, Orit
Shouval, Roni
Shimoni, Avichai
Abraham, Avigdor
Nagler, Arnon
P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title_full P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title_fullStr P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title_full_unstemmed P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title_short P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
title_sort p520: point of care cd19 chimeric antigen receptor (car) t-cells for relapsed/refractory acute myeloid leukemia (aml) with aberrant cd19 antigen expression
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428820/
http://dx.doi.org/10.1097/01.HS9.0000968988.43699.64
work_keys_str_mv AT danyleskoivetta p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT shemtovnoga p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT yerushalmironit p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT jacobyelad p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT torenamos p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT itzhakiorit p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT shouvalroni p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT shimoniavichai p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT abrahamavigdor p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression
AT naglerarnon p520pointofcarecd19chimericantigenreceptorcartcellsforrelapsedrefractoryacutemyeloidleukemiaamlwithaberrantcd19antigenexpression